Byrne, Barry Schoser, Benedikt Kishnani, Priya Bratkovic, Drago Clemens, Paula Goker-Alpan, Ozlem Ming, Xue Roberts, Mark Vorgerd, Matthias Sivakumar, Kumaraswamy
...
Cipaglucosidase alfa plus miglustat (cipa + mig) is a novel, two-component therapy for Pompe disease. We report data from the Phase I/II ATB200-02 study for up to 48 months of treatment. Four adult cohorts, including one non-ambulatory ERT-experienced (n = 6) and three ambulatory cohorts, (two enzyme replacement therapy [ERT]-experienced cohorts [2...
Berry-Kravis, Elizabeth Abbeduto, Leonard Hagerman, Randi Coffey, Christopher S Cudkowicz, Merit Erickson, Craig A McDuffie, Andrea Hessl, David Ethridge, Lauren Tassone, Flora
...
BACKGROUNDFXLEARN, the first-ever large multisite trial of effects of disease-targeted pharmacotherapy on learning, was designed to explore a paradigm for measuring effects of mechanism-targeted treatment in fragile X syndrome (FXS). In FXLEARN, the effects of metabotropic glutamate receptor type 5 (mGluR5) negative allosteric modulator (NAM) AFQ05...
Kesteleyn, Bart; Bonfanti, Jean-Francois; Bardiot, Dorothee; De Boeck, Benoit; Goethals, Olivia; Kaptein, Suzanne J.F.; 51996; Stoops, Bart; Coesemans, Erwin; Fortin, Jerome; Muller, Philippe;
...
Dengue is a global public health threat, with about half of the world's population at risk of contracting this mosquito-borne viral disease. Climate change, urbanization, and global travel accelerate the spread of dengue virus (DENV) to new areas, including southern parts of Europe and the US. Currently, no dengue-specific small-molecule antiviral ...
Volkmann, Elizabeth McMahan, Zsuzsanna Smith, Vanessa Jouneau, Stéphane Miede, Corinna Alves, Margarida Herrick, Ariane
OBJECTIVE: To assess adverse events (AEs) in relation to baseline body mass index (BMI) and the risk of malnutrition in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) treated with nintedanib. METHODS: Among patients with SSc-ILD randomized to receive nintedanib or placebo in the SENSCIS trial, we assessed AEs in sub...
Hervig, Mona El-Sayed Zühlsdorff, Katharina Olesen, Sarah F Phillips, Benjamin Božič, Tadej Dalley, Jeffrey W Cardinal, Rudolf N Alsiö, Johan Robbins, Trevor W
RATIONALE: Cognitive flexibility, the ability to adapt behaviour in response to a changing environment, is disrupted in several neuropsychiatric disorders, including obsessive-compulsive disorder and major depressive disorder. Evidence suggests that flexibility, which can be operationalised using reversal learning tasks, is modulated by serotonergi...
Fnaiche, Ahmed Bueno, Bianca McMullin, Claire L Gagnon, Alexandre
Published in
ChemPlusChem
We disclose herein our detailed investigation into the Barton copper-promoted C3-arylation of indoles using triarylbismuth bis(trifluoroacetates). The arylation of unsubstituted 1H-indole using Barton's conditions gave a low yield of the C3-arylated indole, along with small amounts of the product of double C2/C3-arylation and traces of the product ...
Ezelarab, Hend A. A. Ali, Taha F. S. Abbas, Samar H. Hassan, Heba A. Beshr, Eman A. M.
Published in
BMC Chemistry
Fms-like tyrosine kinase 3 (FLT3) mutation mechanisms are among the most common genetic abnormalities detected in about 30% of acute myeloid leukemia (AML) patients. These mutations are accompanied by poor clinical response, although all these progressions in identifying and interpreting biological AML bio-targets. Several small structured FLT3 inh...
Govaerts, Sebastian
C-N bonds are ubiquitous in natural products and pharmaceuticals. Chemists engaged in the preparation of pharmaceuticals spend a large share of their time forging C-N bonds in their quest for new therapeutics. Methods which allow accessing new nitrogen-containing building blocks more efficiently therefore attract major attention from synthetic chem...
Fizazi, Karim Piulats, Josep M Reaume, M Neil Ostler, Peter McDermott, Ray Gingerich, Joel R Pintus, Elias Sridhar, Srikala S Bambury, Richard M Emmenegger, Urban
...
peer reviewed / [en] BACKGROUND: In a phase 2 study, rucaparib, an inhibitor of poly(ADP-ribose) polymerase (PARP), showed a high level of activity in patients who had metastatic, castration-resistant prostate cancer associated with a deleterious BRCA alteration. Data are needed to confirm and expand on the findings of the phase 2 study. METHODS: I...
Cheng, Cheng Weiss, Lan Leinonen, Henri Shmara, Alyaa Yin, Hong Z Ton, Timothy Do, Annie Lee, Jonathan Ta, Lac Mohanty, Eshanee
...
BackgroundPathogenic gain of function variants in Valosin-containing protein (VCP) cause a unique disease characterized by inclusion body myopathy with early-onset Paget disease of bone and frontotemporal dementia (also known as Multisystem proteinopathy (MSP)). Previous studies in drosophila models of VCP disease indicate treatment with VCP inhibi...